Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in China / NCT03742011
Recruiting Observational

Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study

NCT03742011 · tracked via the Priya Life Science China tracker
Sponsor
Guangzhou Women and Children's Medical Center
Phase
Observational
Started
2012-02-01
Last updated
2024-02-26

Condition(s) studied

PCOSOffspring, AdultHyperandrogenismEpigeneticsInsulin ResistanceEndocrine DisorderMetabolic Disturbance

Study summary

The Offspring Born to Mothers with Polycystic Ovary Syndrome in Guangzhou Cohort study (PCOS-BIG) was established to investigate the short- and long-term effects of intrauterine exposure to maternal PCOS on the health of offspring in Guangzhou, China. Data are collected regarding maternal PCOS subtypes, nursing, diet and education as well as health outcomes in their later life. Biological samples including blood and tissue samples are also collected from participants.

Eligibility

Sex
ALL
Min age
—
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Offspring born to women diagnosed with PCOS * Offspring born to women with \<20 weeks of gestation, intended to eventually deliver in Guangzhou Women and Children's Medical Center * Permanent residents or families intended to remain in Guangzhou for ≥3 years Exclusion Criteria: * None

Primary outcome measure(s)

  • Number of Participants With Abnormal Laboratory Values (Glucolipid metabolism disorders) — An average of 3 years old
    Participants with one or more abnormal laboratory values will be considered as with glucolipid metabolism disorder.

Trial sites (1)

FacilityCityRegionStatus
Guangzhou Women and Children's Medical Center, China Guangzhou Guangdong Recruiting

More Guangzhou Women and Children's Medical Center trials in China

The Born in Guangzhou Cohort Study (BIGCS) Recruiting
Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies Recruiting
CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children. Recruiting
Non-Helium Magnetoencephalography in Pediatric Refractory Epilepsy Recruiting
Non-Helium Magnetoencephalography in Autism Spectrum Disorder Recruiting

Other trials for the same condition

Characteristics of Papez Loop Neural Network in T2DM （Type 2 Diabetes Mellitus） Recruiting
Machine Learning-Based Prediction of Insulin Resistance in Psoriasis Patients Emphasizing Interpretability Active, not recruiting
Liraglutide Treatment in Obese Infertile PCOS Women Recruiting
PIMS vs PGT-A in Infertile PCOS Patients Recruiting
IVF Offspring Born in Guangzhou Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03742011 on ClinicalTrials.gov ↗ ← All trials in China